CXCL12 and glioblastoma: Bajetto et al. also found using a TranswellTM chemotaxis assay in a serum-free medium that the migration of human U87-MG GBM cells was significantly increased in a dose dependent manner by CXCL12 at a concentration varying from 1 to 50 ng/mL.